When one is angry with mTouche, one should look at other companies with lots and lots of $$$ , much much more tham mTouche, and having their share price badly beaten down, you know you will just hve to wait.
I agree with EVO118. There r expectations :). Not happy, sell. Refer to pg 12 n 18, read carefully, understand what real loss is, unavoidable loss etc, then go back to read the rest of the report. Last Q, receivables ( neither pasr due nor impaired) RM 13.3 mil, this Q RM 2.6 mil. $$ not gushing in but trickling. From ordering, receiving to delivering, it can take up to 6-9 months before they can be reported as deliverables ($ due mtouche) in the quarterly financial report. Please, always fact check me. Btw, this counter has a live of its own. It will go up or down when u least expect it.
Take a moment to ponder: why would well known investors park their personal $$$ in a company that does not offer dividend? What did their financial advisors see that is not obvious to people who can't understand how business is run?
The announcement on 31 jan 2021 is the Annual report for financial year ended 30 sept 2021. We will soon know what will be the incoming amount of $$$ fr the covid related sales, fr that last reporting income period , in the next report. ( end February 2022 ????). RM 13 plus million is just the beginning. Do ur market research on the cost of covid test kits n probable large returns fr just trading. Buy fr supplier n sell to buyer. Good traders always make money even without having a lot of money. Only need to be credit worthy.
Read the report carefully. Everything explained in detail. Read part 2 n 3 carefully. Just a small section of Part 3, Revenue fr sales of Covid-19 rapid antigen test kits RM 13.5 Mil. Part 1: pg 9. Covid supplies agreement. Also Group already secured own required permits n relevant approvals.. $$$ is starting to fill mTouche's bank a/c. Need to be patient. Interest fr bank is very low. Anytime can get more return fr investing in mTouche.
I would like to share an interesting observation. Pls refer to section B16 ( Trade receivables)for the 3 last reports ie Sept, June n March. You will see that in Sept : Neither past due n past due but both not impaired n up to 365 days the total amt is RM 33 million. Afer deducting a carry over from the last few months's Past due n impaired, the balance is RM 14.148 million. However, once u compare the numbers with June n March, u will see the receivables in Sept before deduction is jaw dropping. Section B1 will indicate that COVID test kits trading is already in plc. Cant wait to see coming trade receivables when there are no more past impairments to deduct.
A quick look. Depreciation n amortisation etc loss RM 10.55 millions. All should look up the meaning. No way any company can avoid this. NAV better than before rights etc, lots of $ still in the bank.after rights etc. Best to refer to B16, trade receivables. RM14.148 millions. Best value ever. I hope i m not wrong.
Sharing: Quote n unquote: Holding on to anger is like drinking poison and expecting the other person to die. Btw, i hv just seen yesterday's announcement. To me, it is not an announcement i hv to worry about :-) . I hv no intention of selling. Also fr their recent financial report, they hv planned for another RM10 mil for venture into diagnostic kit. This is in addition to the previouse RM 7 mil for the related diagnostic venture expenses. It would be good if the CEO invest more in trading diagnostic kits during this window of opportunity.
Well, i guess i will hv to wait and see if the CEO of mTouche is indeed capable or not when trading in COVID diagnostic kits at a time when there is a huge demand for it and when there is so much $$$ in mTouche' bank account to make a success of it. If he fails, then , low bank interest may indeed be more attractive :-) :-)
Good morning lulgee. I am an investor, not a speculator. I am prepared to wait to see improvements in mTouche's quarterly financial results from now onwards. The share will move when there is renewed confience in its new venture. Depending on contracts, it is quite common for customers/ laboratories to hv at least 3 months to make payment after receiving goods. I hv never given a timeline as to when mTouche's share will go up. Currently, the bank interest rate is not attractive ie i prefer to invest in mTouche's venture in trading in diagnostic kits. I am patient.
Just sharing my thoughts n actions. I hv worked in a diagnostic laboratory before n know they do make handsome profits. Also know those who sell kits to our laboratory makes $$$. Also, based on assumptions made like, if share is RM 0.20 then what can warrant price be? Eg..Share goes fr RM0.10 to RM 0.20 ie 1 X profit ..so warrant RM0.03 ( or RM 0.035) goes to ????...how many fold u think then ....if u think of share at 1.0 then what can warrant price be.. fr 0.030/ 0.035 to etc
Something to think abt. I hv free warrants, bgt some at RM 0.030 and again some at RM 0.025. When the share price goes up , fr profit annoncement, how much more can the warrant price ( percentage wise) go up relative to the share price. Buying warrants does not mean u hv to subscribe if u dont want to. U can sell when it goes up .... go calculate...
Btw, desperate short term speculators, sentiment manipulators and price manipulators are also guilty in pushing the price down...all deperate in wrestling shares from people at low prices when mTouche is on the verge of doing well....all that $$$ in the bank and a demand for diagnostic kits....how can it go wrong
If u go back to their announcement, u will see how much they are paying for the kits. U google the cost ( there is a range depending on where u go for the test)of having to pay for a test. U then roughly factor the cost of overheads, middleman cost and the laboratories' cost ( all cost fr middleman and laborarories will include the profits they want) n u will see that mTouche can make lots of money. Without the $$ fr the rights issue, mTouche will struggle..
The share price dropped but the company's bank account ended up with over RM 100 Mil. This $ provides it with an opportunity to turn the company around with tremendous profit in the near future. It is not difficult to make $$$ selling kits that are in demand. I can see it going back up to AT LEAST RM0.50. All depends on how aggressively they invest n seek out end users ( diagnostic / clinical laboratories). If u dont think they can make money, say why...dont just say con counter..doesn't explain anything. OK?
You hv already said: big players holding most of the shares. They dont get rich buying lousy shares. They won't subscribe to the right unless they are convinced they will make handsome profits. A company can turn around and make profits fr new ventures. This share is going way beyond 10 sens.
The telco/ media industry is like the fashion industry. The designer must come up with attractive designs for the 'fussy' customers. Trading in COVIC diagnostics kits now is like selling ice cream/ cold refreshing drinks during the very hot season.
If not the bottom, at least it is near the bottom. To get another company to buy its shares, the CEO must give a good presentation backed by realistic forecast. To trade in diagnostic kits that are in demand, backed by lots of money in the bank, it is a no brainer that there will be profit to be made. Telco business is v competitive n so there are loses in the past. But this new venture is promising. This is how i see it.
It is good that mTouche has decided to put the 'NEWly' collected money into the very much needed test kits and health industry n not to continuously pour all the money into the competitive loss making business they were in. Their internet platform is still useful. With over 100 million ringgit ...i m so looking forward to the profit with their new venture. Holding tightly to my shares n warrants :-)
On the website: mdar.mda.gov.my...Premier Diagnostics Sdn Bhd has the license for/as: authorised representative, distributor, importer. Expiry date, after extension, is 08 Dec 2024. So, mTouche, working thru/ with Premier Diagnotics, can submit any reliable test kits that they may hv for their conditional approval for use in Malaysia. So.. no issue with license for eligibilty for applications for the next 3 years :-)
In mTouche's past financial report, they hv never mentioned COVID 19 SELF TEST KITs..please go back and check ... :-).... It will be good if they can source for good quality, easy to use, self test kits and apply for the permit too..
mtouche is selling the approved / recommended for use test kits thru companies with the relevant permit. mTouche is expecting to obtain these relevant permits by second half of 2021 when they submit their application by second quarter of 2021. By obtaining the permits, mTouche need not share the profits with the middle man. This venture will lift the share price when they start reporting profits. We just hv to wait.